HK1201153A1 - Intact mass determination of protein conjugated agent compounds - Google Patents
Intact mass determination of protein conjugated agent compoundsInfo
- Publication number
- HK1201153A1 HK1201153A1 HK15101577.2A HK15101577A HK1201153A1 HK 1201153 A1 HK1201153 A1 HK 1201153A1 HK 15101577 A HK15101577 A HK 15101577A HK 1201153 A1 HK1201153 A1 HK 1201153A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- mass determination
- agent compounds
- protein conjugated
- intact mass
- conjugated agent
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161540839P | 2011-09-29 | 2011-09-29 | |
| US201261701489P | 2012-09-14 | 2012-09-14 | |
| PCT/US2012/057649 WO2013049410A1 (fr) | 2011-09-29 | 2012-09-27 | Détermination de la masse intacte de composés agents conjugués à une protéine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1201153A1 true HK1201153A1 (en) | 2015-08-28 |
Family
ID=47996407
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15101577.2A HK1201153A1 (en) | 2011-09-29 | 2015-02-12 | Intact mass determination of protein conjugated agent compounds |
| HK18115512.7A HK1256475A1 (zh) | 2011-09-29 | 2018-12-04 | 蛋白偶聯的試劑化合物的整體分子量測定 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18115512.7A HK1256475A1 (zh) | 2011-09-29 | 2018-12-04 | 蛋白偶聯的試劑化合物的整體分子量測定 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9958455B2 (fr) |
| EP (2) | EP3483611B1 (fr) |
| JP (4) | JP6276186B2 (fr) |
| CN (2) | CN108152513B (fr) |
| AU (1) | AU2012315956B2 (fr) |
| CA (1) | CA2848520C (fr) |
| DK (1) | DK2764351T3 (fr) |
| ES (1) | ES2708699T3 (fr) |
| HK (2) | HK1201153A1 (fr) |
| HU (1) | HUE043154T2 (fr) |
| PL (1) | PL2764351T3 (fr) |
| WO (1) | WO2013049410A1 (fr) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9901567B2 (en) | 2007-08-01 | 2018-02-27 | Syntarga B.V. | Substituted CC-1065 analogs and their conjugates |
| PL3056203T3 (pl) | 2010-04-21 | 2018-06-29 | Syntarga B.V. | Koniugaty analogów CC-1065 i łączników dwufunkcyjnych |
| ES2708699T3 (es) | 2011-09-29 | 2019-04-10 | Seattle Genetics Inc | Determinación de la masa intacta de compuestos de agentes conjugados con proteínas |
| WO2014089177A2 (fr) | 2012-12-04 | 2014-06-12 | Massachusetts Institute Of Technology | Composés, conjugués et compositions d'épipolythiodicétopipérazines et de polythiodicétopipérazines |
| US20160041184A1 (en) * | 2013-03-15 | 2016-02-11 | David R. Barnidge | Identification and monitoring of monoclonal immunoglobulins by molecular mass |
| CA2935430C (fr) | 2014-01-10 | 2018-09-18 | Synthon Biopharmaceuticals B.V. | Conjugues anticorps-medicaments a base de duocarmycine utilisables dans le cadre du traitement du cancer de l'endometre |
| MY177390A (en) | 2014-01-10 | 2020-09-14 | Byondis Bv | Method for purifying cys-linked antibody-drug conjugates |
| WO2015104385A2 (fr) | 2014-01-10 | 2015-07-16 | Synthon Biopharmaceuticals B.V. | Conjugués anticorps-médicament de duocarmycine présentant une meilleure activité antitumorale in vivo |
| WO2015154052A1 (fr) | 2014-04-04 | 2015-10-08 | Mayo Foundation For Medical Education And Research | Isotypage d'immunoglobulines par masse moléculaire précise |
| WO2016018978A1 (fr) | 2014-07-29 | 2016-02-04 | Mayo Foundation For Medical Education And Research | Quantification d'agents thérapeutiques de type anticorps monoclonaux par lc-ms/ms |
| CN105628927B (zh) * | 2014-11-07 | 2020-04-24 | 三生国健药业（上海）股份有限公司 | 一种融合蛋白分子量分析方法 |
| US11566082B2 (en) | 2014-11-17 | 2023-01-31 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
| CN104897826B (zh) * | 2015-06-16 | 2016-06-22 | 广西师范大学 | 一种用于细胞原位检测小分子化合物与靶蛋白相互作用的方法 |
| WO2017053932A1 (fr) | 2015-09-24 | 2017-03-30 | Mayo Foundation For Medical Education And Research | Identification de chaînes légères dépourvues d'immunoglobuline par spectrométrie de masse |
| WO2017107817A1 (fr) * | 2015-12-21 | 2017-06-29 | 江苏恒瑞医药股份有限公司 | Procédé de préparation d'un conjugué anticorps-médicament |
| EP3419637B1 (fr) | 2016-02-25 | 2021-01-27 | Caelus Pharmaceuticals B.V. | Compositions et méthodes de prévention et/ou de traitement d'une carence en vitamine b12 |
| WO2017151892A2 (fr) * | 2016-03-02 | 2017-09-08 | Waters Technologies Corporation | Identification et détermination quantitative de peptides conjugués dans des conjugués anticorps-médicament par spectrométrie de masse |
| US10654887B2 (en) | 2016-05-11 | 2020-05-19 | Ge Healthcare Bio-Process R&D Ab | Separation matrix |
| WO2017194593A1 (fr) | 2016-05-11 | 2017-11-16 | Ge Healthcare Bioprocess R&D Ab | Procédé de nettoyage et/ou de désinfection d'une matrice de séparation |
| US10730908B2 (en) | 2016-05-11 | 2020-08-04 | Ge Healthcare Bioprocess R&D Ab | Separation method |
| US10703774B2 (en) | 2016-09-30 | 2020-07-07 | Ge Healthcare Bioprocess R&D Ab | Separation method |
| US11708390B2 (en) | 2016-05-11 | 2023-07-25 | Cytiva Bioprocess R&D Ab | Method of storing a separation matrix |
| US10918627B2 (en) | 2016-05-11 | 2021-02-16 | Massachusetts Institute Of Technology | Convergent and enantioselective total synthesis of Communesin analogs |
| CN109071613A (zh) | 2016-05-11 | 2018-12-21 | 通用电气医疗集团生物工艺研发股份公司 | 分离基质 |
| US10889615B2 (en) | 2016-05-11 | 2021-01-12 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
| AU2017325022B2 (en) | 2016-09-07 | 2022-10-13 | Mayo Foundation For Medical Education And Research | Identification and monitoring of cleaved immunoglobulins by molecular mass |
| WO2019055634A1 (fr) | 2017-09-13 | 2019-03-21 | Mayo Foundation For Medical Education And Research | Identification et surveillance d'un inhibiteur d'apoptose de macrophage |
| US10640508B2 (en) | 2017-10-13 | 2020-05-05 | Massachusetts Institute Of Technology | Diazene directed modular synthesis of compounds with quaternary carbon centers |
| AU2020211998A1 (en) * | 2019-01-25 | 2021-07-22 | Regeneron Pharmaceuticals, Inc. | Online chromatography and electrospray ionization mass spectrometer |
| BR112021013171A2 (pt) * | 2019-01-25 | 2021-09-28 | Regeneron Pharmaceuticals, Inc. | Cromatografia da proteína a - espectrômetro de massa de ionização por eletropulverização |
| EP3914908A1 (fr) | 2019-01-25 | 2021-12-01 | Regeneron Pharmaceuticals, Inc. | Quantification et identification de dimères dans des co-formulations |
| CN114088852A (zh) * | 2020-08-24 | 2022-02-25 | 上海复旦张江生物医药股份有限公司 | 非变性质谱的分析方法及其装置 |
| CN113289587B (zh) * | 2021-05-10 | 2023-11-28 | 苏州君盟生物医药科技有限公司 | 巯基修饰的磁性纳米微球及其制备方法、应用 |
| CA3230737A1 (fr) | 2021-09-03 | 2023-03-09 | Toray Industries, Inc. | Composition pharmaceutique pour le traitement et/ou la prevention du cancer |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5605690A (en) | 1989-09-05 | 1997-02-25 | Immunex Corporation | Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor |
| US5547853A (en) | 1991-03-12 | 1996-08-20 | Biogen, Inc. | CD2-binding domain of lymphocyte function associated antigen 3 |
| US5635483A (en) | 1992-12-03 | 1997-06-03 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Tumor inhibiting tetrapeptide bearing modified phenethyl amides |
| US5780588A (en) | 1993-01-26 | 1998-07-14 | Arizona Board Of Regents | Elucidation and synthesis of selected pentapeptides |
| ATE282630T1 (de) | 1993-10-01 | 2004-12-15 | Teikoku Hormone Mfg Co Ltd | Dolastatin-derivate |
| US5663149A (en) | 1994-12-13 | 1997-09-02 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides |
| US6043024A (en) * | 1997-04-18 | 2000-03-28 | Abbott Laboratories | Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules |
| JP4586275B2 (ja) | 2001-01-17 | 2010-11-24 | 味の素株式会社 | 複合体の界面を同定する方法 |
| US6884869B2 (en) | 2001-04-30 | 2005-04-26 | Seattle Genetics, Inc. | Pentapeptide compounds and uses related thereto |
| WO2003093817A2 (fr) | 2002-04-29 | 2003-11-13 | Novartis Ag | Methode d'identification de ligands de recepteurs nucleaires |
| DK1545613T3 (da) | 2002-07-31 | 2011-11-14 | Seattle Genetics Inc | Auristatinkonjugater og deres anvendelse til behandling af cancer, en autoimmun sygdom eller en infektiøs sygdom |
| CN1245623C (zh) * | 2003-03-04 | 2006-03-15 | 南京康海药业有限公司 | 香菇多糖分子量及分子量分布测定方法 |
| DK1725249T3 (en) | 2003-11-06 | 2014-03-17 | Seattle Genetics Inc | Monomethylvaline compounds capable of conjugating to ligands. |
| US7375078B2 (en) | 2004-02-23 | 2008-05-20 | Genentech, Inc. | Heterocyclic self-immolative linkers and conjugates |
| US7662936B2 (en) * | 2004-04-07 | 2010-02-16 | Genentech, Inc. | Mass spectrometry of antibody conjugates |
| US20060073528A1 (en) * | 2004-05-14 | 2006-04-06 | Jean-Michel Lecerf | Measurement methods |
| CN101969970B (zh) * | 2007-10-12 | 2014-10-15 | 西雅图基因公司 | 用抗体-药物偶联物联合治疗 |
| US8541178B2 (en) * | 2008-05-13 | 2013-09-24 | Genentech, Inc. | Analysis of antibody drug conjugates by bead-based affinity capture and mass spectrometry |
| TWI326486B (en) | 2008-06-27 | 2010-06-21 | Au Optronics Corp | Method for manufacturing pixel structure |
| ES2708699T3 (es) | 2011-09-29 | 2019-04-10 | Seattle Genetics Inc | Determinación de la masa intacta de compuestos de agentes conjugados con proteínas |
-
2012
- 2012-09-27 ES ES12834802T patent/ES2708699T3/es active Active
- 2012-09-27 EP EP18195890.1A patent/EP3483611B1/fr active Active
- 2012-09-27 EP EP12834802.6A patent/EP2764351B1/fr active Active
- 2012-09-27 JP JP2014533337A patent/JP6276186B2/ja active Active
- 2012-09-27 WO PCT/US2012/057649 patent/WO2013049410A1/fr active Application Filing
- 2012-09-27 CA CA2848520A patent/CA2848520C/fr active Active
- 2012-09-27 PL PL12834802T patent/PL2764351T3/pl unknown
- 2012-09-27 DK DK12834802.6T patent/DK2764351T3/en active
- 2012-09-27 AU AU2012315956A patent/AU2012315956B2/en active Active
- 2012-09-27 HU HUE12834802A patent/HUE043154T2/hu unknown
- 2012-09-27 US US14/346,670 patent/US9958455B2/en active Active
- 2012-09-27 CN CN201810094123.4A patent/CN108152513B/zh active Active
- 2012-09-27 CN CN201280047453.9A patent/CN103858003B/zh active Active
-
2015
- 2015-02-12 HK HK15101577.2A patent/HK1201153A1/xx unknown
-
2018
- 2018-01-11 JP JP2018002748A patent/JP6496050B2/ja active Active
- 2018-03-19 US US15/925,639 patent/US11169158B2/en active Active
- 2018-12-04 HK HK18115512.7A patent/HK1256475A1/zh unknown
-
2019
- 2019-03-07 JP JP2019041551A patent/JP6770123B2/ja active Active
-
2020
- 2020-09-24 JP JP2020159739A patent/JP6997271B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11169158B2 (en) | 2021-11-09 |
| CN108152513B (zh) | 2020-07-24 |
| HK1256475A1 (zh) | 2019-09-27 |
| JP6770123B2 (ja) | 2020-10-14 |
| JP2019105650A (ja) | 2019-06-27 |
| JP6276186B2 (ja) | 2018-02-07 |
| HUE043154T2 (hu) | 2019-08-28 |
| CA2848520C (fr) | 2019-11-26 |
| CN103858003B (zh) | 2018-06-22 |
| JP6997271B2 (ja) | 2022-01-17 |
| WO2013049410A1 (fr) | 2013-04-04 |
| CN108152513A (zh) | 2018-06-12 |
| ES2708699T3 (es) | 2019-04-10 |
| JP6496050B2 (ja) | 2019-04-03 |
| AU2012315956A1 (en) | 2014-03-27 |
| EP2764351A1 (fr) | 2014-08-13 |
| EP2764351A4 (fr) | 2015-05-27 |
| US9958455B2 (en) | 2018-05-01 |
| JP2021004889A (ja) | 2021-01-14 |
| CN103858003A (zh) | 2014-06-11 |
| US20180275137A1 (en) | 2018-09-27 |
| EP3483611B1 (fr) | 2023-01-04 |
| EP3483611A1 (fr) | 2019-05-15 |
| CA2848520A1 (fr) | 2013-04-04 |
| PL2764351T3 (pl) | 2019-05-31 |
| JP2018063265A (ja) | 2018-04-19 |
| JP2014531596A (ja) | 2014-11-27 |
| EP2764351B1 (fr) | 2018-11-07 |
| US20140242624A1 (en) | 2014-08-28 |
| DK2764351T3 (en) | 2019-01-28 |
| AU2012315956B2 (en) | 2016-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1256475A1 (zh) | 蛋白偶聯的試劑化合物的整體分子量測定 | |
| HRP20190576T1 (hr) | Postupci pripreme konjugata | |
| GB2498228B (en) | Provision of an open instance of an application | |
| EP2773651A4 (fr) | Compositions spécifiques de b7-h4 isolé et procédés d'utilisation associés | |
| EP2677014A4 (fr) | Composition à base d'un agent adhésif | |
| ZA201403090B (en) | Tropicalizing agent | |
| HK1183146A1 (zh) | 基元組成 | |
| HK1201469A1 (en) | Compositions and methods for hemostasis | |
| ZA201308399B (en) | Improved composition | |
| ZA201401430B (en) | Improved explosive composition | |
| EP2690081A4 (fr) | Composition d'agent générateur de gaz | |
| HK1199927A1 (en) | Explosive composition | |
| GB201107181D0 (en) | Deodorising composition | |
| ZA201308152B (en) | Pharmaceutical antiretroviral composition | |
| EP2692715A4 (fr) | Composition d'agent gazogène | |
| EP2694705A4 (fr) | Microfabrication de tunnels | |
| HK1199040A1 (en) | Use of antibody | |
| ZA201402166B (en) | Compositions of efavirenz | |
| ZA201308856B (en) | Coalescing agents composition | |
| EP2684869A4 (fr) | Préparation de 3-mercaptopropionates | |
| EP2787050A4 (fr) | Agent de formation d'organogel lécithine | |
| TWI562734B (en) | Sense-improving agent | |
| EP2764870A4 (fr) | Agent aiguisant les sens | |
| ZA201400527B (en) | Encapsulated benefit agent | |
| EP2792346A4 (fr) | Composition manucure |